New Player Enters Californian Cannabis Testing Market
Formed by Sachin Barot and Denis Chen, the CERESLabs mission is to become the global leader in analytical cannabis product testing.
Trends in Medical Marijuana Use in Washington State
About 1 in 7 adult primary care patients visiting medical offices reported having used marijuana at least once in the past year.
Steep Hill, Eybna Partner to Commercialize Customized Cannabis Terpene Products
The partnership will utilize Steep Hill's expertise in analytical testing to customize Eybna's production of terpene formulations for optimizing the medical benefits of cannabis.
Taking Advantage of Canada’s Cannabis Testing Market
Third party lab testing isn’t currently required by Health Canada, but the agency has already required ‘expanded’ testing for licensed producers to ensure that pesticide and additive requirements are being met.
Steep Hill Expands Into Oregon
Jmîchaeĺe Keller, President and CEO of Steep Hill has announced that it has licensed its cannabis testing technology to highly respected pain and addiction physician Dr. Carl Balog.
Tilray Takes Medical Cannabis to the EU
This is the first time a company has legally exported live cannabis genetics from North America to Europe.
Almost 70% of CBD Extracts Sold Online Are Mislabeled
Products containing either too little or too much CBD than labeled could negate potential clinical benefit to patients.
Can Cannabinoids Be Used to Treat Cancer?
When cannabinoids activate signaling pathways in cancer cells they can stimulate a cell death mechanism called apoptosis, unleashing a potent anti-tumor effect.
FDA Warns Companies Marketing Unproven Cannabis-derived Products
The agency has issued warning letters to four companies illegally selling products online that claim to prevent, diagnose, treat, or cure cancer without evidence to support these outcomes.
